Inventor · disambiguated record
Willem Karel Bleeker
Also filed as: BLEEKER WILLEM KAREL
8 granted patents·13 pending applications·45 citations·filing 1995–2025
85Inventor score
Top patents by PatentIndex Score
21 records- 0190US9714297B2Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2015·Granted Jul 25, 2017·9 cites·29 claims
- 0290US9150658B2Human antibodies against tissue factor and methods of use thereofVERPLOEGEN SANDRA·Filed 2009·Granted Oct 6, 2015·20 cites·43 claims
- 0382US10351629B2Recombinant IgG4 monovalent antibodiesGENMAB AS·Filed 2016·Granted Jul 16, 2019·2 cites·24 claims
- 0482US2023416403A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2022·Application pending·0 cites
- 0580US9540433B2Human antibodies and antibody-drug conjugates against CD74VERPLOEGEN SANDRA·Filed 2012·Granted Jan 10, 2017·6 cites·43 claims
- 0679US9322035B2Recombinant IgG4 monovalent antibodiesSCHUURMAN JANINE·Filed 2008·Granted Apr 26, 2016·2 cites·6 claims
- 0779US2025340669A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2025·Application pending·0 cites
- 0873US10155816B2Recombinant monovalent antibodies and methods for production thereofPARREN PAUL·Filed 2006·Granted Dec 18, 2018·1 cites·17 claims
- 0972US2022396629A1Recombinant monovalent antibodies and methods for production thereofGENMAB AS·Filed 2022·Application pending·0 cites
- 1069US2022323582A1Human antibodies and antibody-drug conjugates against cd74GENMAB AS·Filed 2021·Application pending·0 cites
- 1169US2021171657A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2020·Application pending·0 cites
- 1264US2019169311A1Human Antibodies Against Tissue Factor and Methods of Use ThereofGENMAB AS·Filed 2018·Application pending·0 cites
- 1357US2019169298A1Recombinant monovalent antibodies and methods for production thereofGENMAB AS·Filed 2018·Application pending·0 cites
- 1451US2010255012A1Recombinant fucose modified monovalent half-antibodies obtained by molecular engineeringGENMAB AS·Filed 2008·Application pending·0 cites
- 1549US9540450B2Methods and antibodies for treating cancerGENMAB AS·Filed 2014·Granted Jan 10, 2017·0 cites·14 claims
- 1649US2010325744A1Non-glycosylated recombinant monovalent antibodiesGENMAB AS·Filed 2008·Application pending·0 cites
- 1749US2011045007A1Fusion or linked proteins with extended half lifeGENMAB AS·Filed 2008·Application pending·0 cites
- 1849US2010291023A1Method for extending the half-life of exogenous or endogenous soluble moleculesGENMAB AS·Filed 2008·Application pending·0 cites
- 1949US2017173151A1Human antibodies and antibody-drug conjugates against cd74GENMAB AS·Filed 2016·Application pending·0 cites
- 2048US2011256142A1Novel methods and antibodies for treating cancerGENMAB AS·Filed 2008·Application pending·0 cites
- 2137US5646252AHemoglobin composition and preparation thereofNEDERLANDEN STAAT·Filed 1995·Granted Jul 8, 1997·5 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Willem Karel Bleeker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →